Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 613-624
Open Access | Times Cited: 6

Showing 6 citing articles:

Calcium signaling hypothesis: A non-negligible pathogenesis in Alzheimer’s disease
Minghui Wang, Hu Zhang, Jiling Liang, et al.
Journal of Advanced Research (2025)
Open Access
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access
Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer′s disease
Sergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojakovic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Equity of access in rural and metropolitan dementia diagnosis, management, and care experiences: an exploratory qualitative study
Hannah Gulline, Sarah Carmody, Mark Yates, et al.
International Journal for Equity in Health (2025) Vol. 24, Iss. 1
Open Access
Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions
Jeffrey L. Cummings
Neurotherapeutics (2025), pp. e00570-e00570
Open Access
Knowing the enemy: strategic targeting of complement to treat Alzheimer disease
Andrea J. Tenner, Tiffany J. Petrisko
Nature Reviews Neurology (2025)
Closed Access
Geographic Variation in Shortfalls of Dementia Specialists in the U.S.
Jodi Liu, Lawrence Baker, Annie Yu-An Chen, et al.
Health Affairs Scholar (2024) Vol. 2, Iss. 7
Open Access | Times Cited: 2
Combined administration of catalpol, puerarin, gastrodin, and borneol modulates the Tlr4/Myd88/NF-κB signaling pathway and alleviates microglia inflammation in Alzheimer’s disease
Huijing Ren, Ling Tang, Zhiying Yuan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Page 1

Scroll to top